• Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages

    Источник: Buzz FX / 25 ноя 2024 03:31:10   America/Chicago


    Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat November 25, 2024 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has received an average r
    Read more...
Опубликовать